PO-1247 Predictive factors for 90 day mortality in stage III NSCLC patients treated with chemo-radiotherapy. (May 2022) - Lambrecht, M.; Van de Velde, A.; Verfaillie, S.; Defraene, G.; Berkovic, P.; Dooms, C.; Vansteenkiste, J.; Wauters, E.